Noninvasive Prenatal Testing

Noninvasive Prenatal Testing (NIPT) is a blood test for pregnant women that screens for certain genetic conditions and chromosomal abnormalities in the fetus, such as Down syndrome. It analyzes small fragments of fetal DNA circulating in the mother's bloodstream, providing information about the baby's genetic makeup without risky procedures like amniocentesis. NIPT is highly accurate, safe, and can typically be done as early as 10 weeks of pregnancy, helping expectant parents and healthcare providers make informed decisions about further testing or management.